Internal Audit Analyst III, Global Internal Audit & Assurance (EG 100) at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

A BA/BS degree in Data Science, Computer Science, Information Systems, Accounting, Finance, or other business discipline
A minimum of 4 years prior public accounting or internal audit experience, including experience in financial, operational, IT or compliance auditing
Knowledge of U.S. GAAP and IIA standards
English fluency
Strong verbal (implied from context)

Responsibilities

Work collaboratively with audit teams to execute financial, operational, compliance, and integrated-IT audits
Conduct planning activities to identify significant risks and develop appropriate risk-based audit procedures
Research applicable policies, guidance, and regulations to drive assigned sections of the audit with high quality and within deadlines
Leverage existing data analytics AI use cases and assist with build and enhancement projects, when assigned
Interview key personnel to assess business processes and the strength of their control environments
Identify meaningful value-added recommendations for management to improve the adequacy, effectiveness, and efficiency of controls and related processes
Lead meetings involving various levels of management to effectively communicate audit status, align on significant audit issues and recommended corrective actions
Prepare clear, detailed audit documentation evidencing the results of actual testing procedures in accordance with BMS and the Institute of Internal Auditors (IIA) standards
Prepare audit reports, including clearly written, concise audit observations that effectively communicate identified issues and their related corrective actions to key stakeholders
Participate with the team in trainings and regular departmental meetings that include sharing best practices
Participate in departmental projects as assigned (e.g., audit lessons learned, training, continuous improvement, etc.)

Skills

Internal Audit

IT Audit

Risk-Based Auditing

Audit Planning

Audit Execution

Process Controls

Third-Party Audits

Control Assessment

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free